ClinicalTrials.Veeva

Menu

A Retrospective Review of FloSeal Use in Total Shoulder Arthroplasty

W

Western Orthopaedics Research and Education Foundation

Status

Completed

Conditions

Glenohumeral Osteoarthritis
Total Shoulder Arthroplasty

Study type

Observational

Funder types

Other

Identifiers

NCT01726972
369439-1

Details and patient eligibility

About

The proposed study aims to objectively assess 2-year clinical and radiographic results for the rate of glenoid component loosening in total shoulder arthroplasty (TSA). This retrospective radiographic review will provide evidence for equivalence or superiority in curtailing loosening, a known complication in arthroplasty, when a hemostatic agent is utilized in conjunction with cement at the glenoid.

Enrollment

41 patients

Sex

All

Ages

21 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients must have completed at least 2 years follow-up following their total shoulder replacement
  • Patients must have had radiographic imaging obtained at that 2 years

Exclusion criteria

  • Patients less than 21 years of age
  • Patients who have been imprisoned since the time of surgery
  • Patients who are mentally impaired

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems